| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7019002 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents |
| 03/28/2006 | US7019001 Substituted benzothiazole amide derivatives |
| 03/28/2006 | US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer |
| 03/28/2006 | US7018999 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound. |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018997 Tricyclic 6-alkylidene-penems as β-lactamase inhibitors |
| 03/28/2006 | US7018995 Carbonate and carbamate modified forms of glucocorticoids |
| 03/28/2006 | US7018994 Antiestrogen compound |
| 03/28/2006 | US7018993 Androstane derivatives having various substituents at positions 7 and/or 11, a prophylactic or therapeutic agent for a disease selected from prostate cancer, benign prostatic hyperplasia, alopecia, acne, precocioous puberty |
| 03/28/2006 | US7018992 Hormone composition |
| 03/28/2006 | US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides |
| 03/28/2006 | US7018990 synergistic mixture with 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-5-[[4-[(2'-dimethylaminomethyl)imidazol-1'-yl]-2-fluorophenyl]aminocarbonyl]pyrazole-hydrochloric acid salt (Razaxaban) allows for lower dosages of each agent; thromboembolic disorders; anticoagulants; decreased bleeding times |
| 03/28/2006 | US7018989 Chemical compounds |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7018987 Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof |
| 03/28/2006 | US7018986 Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018984 Methods and compositions for controlling translation of HCV proteins |
| 03/28/2006 | US7018983 Administering pharmaceutical composition comprising a sulfamate |
| 03/28/2006 | US7018982 Methods useful in the treatment of bone resorption diseases |
| 03/28/2006 | US7018979 simultaneous administration of agonist and anticarcinogenic agent; potassium channel agonist is not bradykinin or a bradykinin analog, but can be a guanylyl cyclase activator, a guanylyl cyclase activating protein, minoxidil, pinacidil, cromakalim, or levcromakalim |
| 03/28/2006 | US7018797 Method for treating neurodegenerative disorders |
| 03/28/2006 | US7018796 Detection of modulators of viral enzymatic activity; obtain sample containing viral enzyme, incubate with modulator and substrate, monitor adjustment in enzyme activity |
| 03/28/2006 | US7018661 Aluminum-zirconium compound-based treatment for herpes simplex virus lesions |
| 03/28/2006 | US7018660 For therapy of seborrheic dermatitis, psoriasis, folliculitis, rosacea, perioral dermatitis, acne, or impetigo |
| 03/28/2006 | US7018658 Pharmaceutical pellets comprising tamsulosin |
| 03/28/2006 | US7018656 Gel formulations of 1-hydroxy-2(H)pyridone derivatives, which contain solvents and hydrophilic gel-forming agents |
| 03/28/2006 | US7018652 Composition and method for treating nonalcoholic steatohepatitis |
| 03/28/2006 | US7018649 Felodipine transdermal device and methods |
| 03/28/2006 | US7018646 Apparatus and method for delivering controlled quantities of one or more agents to the eye |
| 03/28/2006 | US7018635 Semi-refined carrageenan |
| 03/28/2006 | US7018631 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 03/28/2006 | US7018625 Personal care compositions |
| 03/28/2006 | US7018624 Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels |
| 03/28/2006 | US7018621 dosage form serotonin agonists comprising aerosols formed by heating layers of the drugs on solid supports, to form vapors, then condensing to form condensates which can be administered by breathing; prophylaxis of headaches |
| 03/28/2006 | US7018620 Delivery of beta-blockers through an inhalation route |
| 03/28/2006 | US7018619 Administering a therapeutic amount of an alprazolam, estazolam, midazolam or triazolam condensation aerosol for therapy of anxiety or insomnia |
| 03/28/2006 | US7018618 An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter of |
| 03/28/2006 | US7018395 to destroy or impair target cells expressing a vascular endothelial growth factor (VEGF) receptor by administering a liposome system of conjugated antibodies, conjugated photosensitizer and another liposome conjugate and using light of an intensity such that nontarget cells are not destroyed |
| 03/28/2006 | US7018370 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/28/2006 | CA2386793C New selective retinoid agonists |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/28/2006 | CA2290963C S-omeprazole magnesium trihydrate |
| 03/28/2006 | CA2290392C Salts of optically active sulfoxide derivative |
| 03/28/2006 | CA2276011C A method to prepare food seasoning, food ingredient and food item compositions, seasoning and use thereof |
| 03/28/2006 | CA2263417C Arylalkanoylpyridazines |
| 03/28/2006 | CA2253912C Taxane derivatives, the preparation thereof and formulations containing them |
| 03/28/2006 | CA2252229C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 03/28/2006 | CA2244862C Substituted amide derivatives |
| 03/28/2006 | CA2242865C Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| 03/28/2006 | CA2209696C Use of a polysaccharide in a composition designed to stimulate the immune defences, and the composition in which it is included |
| 03/28/2006 | CA2156121C Method of manufacturing the cycloheptimidazole derivatives |
| 03/28/2006 | CA2153805C C10 taxane derivatives and pharmaceutical compositions |
| 03/28/2006 | CA2147451C 3-indolylpiperidines |
| 03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/28/2006 | CA2096723C Methods and compositions for the suppression of neu mediated transformation |
| 03/23/2006 | WO2006032026A2 Long acting injectable crystal formulations of estradiol metabolites and methods of using same |
| 03/23/2006 | WO2006032023A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 03/23/2006 | WO2006032011A2 Combination therapy for controlled carbohydrate digestion |
| 03/23/2006 | WO2006031980A2 Treatment for cancer-related fatigue |
| 03/23/2006 | WO2006031969A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 03/23/2006 | WO2006031943A1 Compounds, compositions and methods for controlling biofilms and bacterial infections |
| 03/23/2006 | WO2006031931A2 Reducing er stress in the treatment of obesity and diabetes |
| 03/23/2006 | WO2006031930A2 Modulation of xbp-1 activity for treatment of metabolic disorders |
| 03/23/2006 | WO2006031929A2 Thiazolopyridine kinase inhibitors |
| 03/23/2006 | WO2006031922A2 Thyroid hormone analogs for promoting angiogenesis |
| 03/23/2006 | WO2006031894A2 Methods of treating a disorder |
| 03/23/2006 | WO2006031852A1 Vanilloid receptor ligands and their use in treatments |
| 03/23/2006 | WO2006031848A2 Corticosteroid topical dispersion with low content of surfactant |
| 03/23/2006 | WO2006031806A2 2-thiopyrimidinones as therapeutic agents |
| 03/23/2006 | WO2006031799A2 Compositions comprising ubiquinones |
| 03/23/2006 | WO2006031782A2 Salvinorin derivatives as opioid receptor ligands |
| 03/23/2006 | WO2006031772A1 Methods of treating proliferative skin diseases using carbazole derivatives |
| 03/23/2006 | WO2006031756A2 Betulinol derivatives as anti-cancer agents |
| 03/23/2006 | WO2006031725A2 Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
| 03/23/2006 | WO2006031719A2 1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof |
| 03/23/2006 | WO2006031706A2 Betulinol derivatives as anti-hiv agents |
| 03/23/2006 | WO2006031683A2 Compositions containing uridine, and methods utilizing same |
| 03/23/2006 | WO2006031676A2 Tricyclic anilide spirohydantoin cgrp receptor antagonists |
| 03/23/2006 | WO2006031674A1 Process for preparing n-(substituted arylmethyl)-4-substituted-4- (disubstituted methyl) piperidines and intermediates |
| 03/23/2006 | WO2006031614A2 Reduced toxicity methotrexate formulations and methods for using the same |
| 03/23/2006 | WO2006031610A2 Bicyclic anilide spirolactam cgrp receptor antagonists |
| 03/23/2006 | WO2006031606A2 Carboxamide spirolactam cgrp receptor antagonists |
| 03/23/2006 | WO2006031566A2 Halogenated benzamide derivatives |
| 03/23/2006 | WO2006031556A2 Amidine substituted aryl aniline compounds |
| 03/23/2006 | WO2006031513A2 Aryl spirolactam cgrp receptor antagonists |
| 03/23/2006 | WO2006031505A1 Purine derivatives as a3 and a1 adenosine receptor agonists |
| 03/23/2006 | WO2006031491A2 Tricyclic anilide spirolactam cgrp receptor antagonists |
| 03/23/2006 | WO2006031388A2 Dentritic polymers, crosslinked gels, and their uses in orthopedic applications |
| 03/23/2006 | WO2006031376A2 Use of antioxidants for treating degenerative disc disease |
| 03/23/2006 | WO2006031358A2 Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses |
| 03/23/2006 | WO2006031357A2 Fluorescent fused-ring triazoles that inhibit cell proliferation and uses thereof |
| 03/23/2006 | WO2006031348A2 Mitotic kinesin inhibitors |
| 03/23/2006 | WO2006031337A2 Combinations of pkc activators and pkc inhibitors for alzheimer’s disease treatment and cognitive enhancement |
| 03/23/2006 | WO2006031293A2 Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia |
| 03/23/2006 | WO2006031267A2 Rna interference suppression of neurodegenerative diseases and methods of use thereof |